Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Starling

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Journal of Child Neurology|March 4, 2017
The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade StudentsDavid Dodick, Amaal J Starling, Jennifer Wethe, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)Bryan H Norman, Joseph M Gruber, Sean P Hollinshead, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Cancer Discovery|January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1)Bryan H Norman, Peter A Lander, Joseph M Gruber, et al.
Advances in Enzyme Regulation|January 1, 1997
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoproteinJ J Starling, R L Shepard, J Cao, et al.
Headache|July 11, 2020
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid UseKarissa N Arca, Jonathan H Smith, Chia-Chun Chiang, et al.
British Journal of Haematology|April 10, 2008
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implicationsKenji Ishitsuka, Teru Hideshima, Paola Neri, et al.
Journal of Medicinal Chemistry|October 29, 2009
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabineDavid M Bender, Jingqi Bao, Anne H Dantzig, et al.
Cephalalgia : an International Journal of Headache|May 24, 2015
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)Richard B Lipton, Daniel Serrano, Dawn C Buse, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Journal of Child Neurology|March 4, 2017
The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade StudentsDavid Dodick, Amaal J Starling, Jennifer Wethe, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)Bryan H Norman, Joseph M Gruber, Sean P Hollinshead, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Cancer Discovery|January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1)Bryan H Norman, Peter A Lander, Joseph M Gruber, et al.
Advances in Enzyme Regulation|January 1, 1997
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoproteinJ J Starling, R L Shepard, J Cao, et al.
Headache|July 11, 2020
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid UseKarissa N Arca, Jonathan H Smith, Chia-Chun Chiang, et al.
British Journal of Haematology|April 10, 2008
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implicationsKenji Ishitsuka, Teru Hideshima, Paola Neri, et al.
Journal of Medicinal Chemistry|October 29, 2009
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabineDavid M Bender, Jingqi Bao, Anne H Dantzig, et al.
Cephalalgia : an International Journal of Headache|May 24, 2015
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)Richard B Lipton, Daniel Serrano, Dawn C Buse, et al.
Pageof 16